Captive Insurance in Abbott Park, Illinois 60064

Attention: open in a new window. PDFPrintE-mail

Capstone Insurance Management, Ltd. (CIMA), which is both a licensed captive insurance manager and a licensed company manager, facilitates captive planning whether done in the U.S. or offshore. Today, CIMA is among the largest and most active captive managers in Abbott Park, Illinois 60064. To get more information, please fill out the form below.

 


 

Local News

Abbott Park Illinois - Yahoo! News Search Results

Abbott Park Illinois - Yahoo! News Search Results

  • — Americaneagle.com Recognized With 8 Horizon Interactive Awards for 2011

       (Tuesday, 08 May 2012 15:09)

    PARK RIDGE, IL-- - Americaneagle.com, a leading website design, development and hosting company, today announced that they have been recognized for their online excellence with eight awards in four different ...

  • — Press Release

       (Tuesday, 08 May 2012 05:09)

    Abbott Park, Illinois (NYSE: ABT) and Aarhus, Denmark, — Abbott and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.

  • — Abbott Laboratories to pay $1.6 billion over misbranding drug

       (Monday, 07 May 2012 18:29)

    Abbott Laboratories has pleaded guilty and agreed to pay $1.6 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department said Monday.

  • — Drug misbranding leads to $1.5B fine

       (Monday, 07 May 2012 18:29)

    Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department announced Monday.

  • — Abbott Laboratories pays $1.5 million over misbranding drug

       (Monday, 07 May 2012 17:03)

    Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote, the U.S. Justice Department announced Monday.